Benutzerspezifische Werkzeuge

Information zum Seitenaufbau und Sprungmarken fuer Screenreader-Benutzer: Ganz oben links auf jeder Seite befindet sich das Logo der JLU, verlinkt mit der Startseite. Neben dem Logo kann sich rechts daneben das Bannerbild anschließen. Rechts daneben kann sich ein weiteres Bild/Schriftzug befinden. Es folgt die Suche. Unterhalb dieser oberen Leiste schliesst sich die Hauptnavigation an. Unterhalb der Hauptnavigation befindet sich der Inhaltsbereich. Die Feinnavigation findet sich - sofern vorhanden - in der linken Spalte. In der rechten Spalte finden Sie ueblicherweise Kontaktdaten. Als Abschluss der Seite findet sich die Brotkrumennavigation und im Fussbereich Links zu Barrierefreiheit, Impressum, Hilfe und das Login fuer Redakteure. Barrierefreiheit JLU - Logo, Link zur Startseite der JLU-Gießen Direkt zur Navigation vertikale linke Navigationsleiste vor Sie sind hier Direkt zum Inhalt vor rechter Kolumne mit zusaetzlichen Informationen vor Suche vor Fußbereich mit Impressum

Titel

Artikelaktionen

Publikationen 2019

Wagenlehner FME, Cloutier DJ, Komirenko AS, Cebrik DS, Krause KM, Keepers TR, Connolly LE, Miller LG, Friedland I, Dwyer JP; EPIC Study Group: Once-Daily Plazomicin for Complicated Urinary Tract Infections. N Engl J Med 380(8):729-740 (2019)
 
Tandogdu Z, Koves B, Cai T, Cek M, Tenke P, Naber K, Wagenlehner F, Johansen TEB: Condition-specific surveillance in health care-associated urinary tract infections as a strategy to improve empirical antibiotic treatment: an epidemiological modelling study. World J Urol. 2019 Sep 25. doi: 10.1007/s00345-019-02963-9. [Epub ahead of print]
 
Bausch K, Kulchavenya E, Wagenlehner F, Bonkat G: Urological infections and migration. Urologe Sep 24. doi: 10.1007/s00120-019-01040-8. [Epub ahead of print] (2019)
 
Alidjanov JF, Naber KG, Pilatz A, Radzhabov A, Zamuddinov M, Magyar A, Tenke P, Wagenlehner FM: Additional assessment of Acute Cystitis Symptom Score questionnaire for patient-reported outcome measure in female patients with acute uncomplicated cystitis: part II. World J Urol Sep 23. doi: 10.1007/s00345-019-02948-8. [Epub ahead of print] (2019)
 
Pilatz A, Kilb J, Kaplan H, Fietz D, Hossain H, Schüttler CG, Diemer T, Bergmann M, Domann E, Weidner W, Wagenlehner F, Schuppe HC: High prevalence of urogenital infection/inflammation in patients with azoospermia does not impede surgical sperm retrieval. Andrologia 27:e13401 (2019)
 
Spachmann PJ, May M, Vetterlein MW, Fritsche HM, Steffen S, Schostak M, Wagenlehner FM, Burger M, Weylandt KH, Salzberger B, Brookman-May SD, Gilfrich C; MR2 study group: Awareness and perception of multidrug-resistant organisms and antimicrobial therapy among internists vs. surgeons of different specialties: Results from the German MR2 Survey. Caspian J Intern Med Spring 10(2):132-141 (2019)
 
Liedl B, Goeschen K, Wagenlehner F: Re: Benoit Peyronnet, Emma Mironska, Christopher Chapple, et al. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol 2019;75:988-1000: Overactive Bladder Symptoms Can Be Caused by Pelvic Organ Prolapse. Eur Urol 76(4):e105-e106 (2019)
 
Schulz M, Zambrano F, Schuppe HC, Wagenlehner F, Taubert A, Ulrich G, Sánchez R, Hermosilla C: Determination of leucocyte extracellular traps (ETs) in seminal fluid (ex vivo) in infertile patients-A pilot study. Andrologia. 51(9):e13356 (2019)
 
Bruyere F, Pilatz A, Boehm A, Pradere B, Wagenlehner F, Vallee M: Associated measures to antibiotic prophylaxis in urology. World J Urol doi: 10.1007/s00345-019-02854-z. [Epub ahead of print] (2019)
 
Bonkat G, Pilatz A, Wagenlehner F: Time to Adapt Our Practice? The European Commission Has Restricted the Use of Fluoroquinolones since March 2019. Eur Urol 76(3):273-275 (2019)
 
Liedl B, Sutherland S, Gunnemann A, Witczak M, Wagenlehner F: Urethral closure is by a musculo-elastic mechanism, not pressure transmission. Neurourol Urodyn 38(6):1793-1794 (2019)
 
Schulz M, Zambrano F, Schuppe HC, Wagenlehner F, Taubert A, Gaertner U, Sánchez R, Hermosilla C:
Monocyte-derived extracellular trap (MET) formation induces aggregation and affects motility of human spermatozoa in vitro. Syst Biol Reprod Med 65(5):357-366 (2019)
 
Kongnakorn T, Wagenlehner F, Falcone M, Tichy E, Di Virgilio R, Baillon-Plot N, Charbonneau C: Cost-effectiveness analysis of ceftazidime/avibactam compared to imipenem as empirical treatment for complicated urinary tract infections. Int J Antimicrob Agents S0924-8579(19)30161-X (2019)
 
Johansen TEB, Zahl PH, Baco E, Bartoletti R, Bonkat G, Bruyere F, Cai T, Cek M, Kulchavenya E, Köves B, Mouraviev V, Pilatz A, Tandogdu Z, Tenke P, Wagenlehner FME: Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry. World J Urol s00345-019-02837-0. [Epub ahead of print] (2019)
 
Pilatz A, Fijak M, Wagenlehner F, Schuppe HC: Orchitis. Urologe 58(6):697-710 (2019)
 
Wagenlehner FM, Naber KG: A step further in a vaccine for Escherichia coli. Lancet Infect Dis 19(6):565-567 (2019)
 
Loose M, Naber KG, Hu Y, Coates A, Wagenlehner FME: Urinary bactericidal activity of colistin and azidothymidine combinations against mcr-1-positive colistin-resistant Escherichia coli. Int J Antimicrob Agents 54(1):55-61 (2019)
 
Tandogdu Z, Kakariadis ETA, Naber K, Wagenlehner F, Bjerklund Johansen TE: Appropriate empiric antibiotic choices in health care associated urinary tract infections in urology departments in Europe from 2006 to 2015: A Bayesian analytical approach applied in a surveillance study. PLoS One 25;14(4):e0214710 (2019)
 
Alidjanov JF, Naber KG, Pilatz A, Radzhabov A, Zamuddinov M, Magyar A, Tenke P, Wagenlehner FM: Evaluation of the draft guidelines proposed by EMA and FDA for the clinical diagnosis of acute uncomplicated cystitis in women. World J Urol doi: 10.1007/s00345-019-02761-3. [Epub ahead of print] (2019)
 
Dixon M, Stefil M, McDonald M, Bjerklund-Johansen TE, Naber K, Wagenlehner F, Mouraviev V: Metagenomics in diagnosis and improved targeted treatment of UTI. World J Urol doi: 10.1007/s00345-019-02731-9. (2019)
 
Schnabel MJ, Wagenlehner FME, Schneidewind L: Perioperative antibiotic prophylaxis for stone therapy. Curr Opin Urol 29(2):89-95 (2019)
 
Magri V, Boltri M, Cai T, Colombo R, Cuzzocrea S, De Visschere P, Giuberti R, Granatieri CM, Latino MA, Larganà G, Leli C, Maierna G, Marchese V, Massa E, Matteelli A, Montanari E, Morgia G, Naber KG, Papadouli V, Perletti G, Rekleiti N, Russo GI, Sensini A, Stamatiou K, Trinchieri A, Wagenlehner FME: Multidisciplinary approach to prostatitis. Arch Ital Urol Androl 18;90(4):227-248 (2019)
 
Kranz J, Schlager D, Mühlstädt S, Nagler J, Wagenlehner FME, Schneidewind L: Barriers to guideline adherence : Identification of barriers to guideline adherence using a survey on the AWMF S3 guideline epidemiology, diagnosis, treatment, and management of uncomplicated bacterial, community-acquired urinary tract infections in adult patients. Urologe 58(9):1019-1028 (2019)
 
Wagenlehner FME, Naber KG: Cefiderocol for treatment of complicated urinary tract infections. Lancet Infect Dis 19(1):22-23 (2019)
 
Naber KG, Wagenlehner FME: Novel Antibiotics in the Treatment of Urinary Tract Infections. Eur Urol Focus 5(1):10-12 (2019)
 
Köves B, Tenke P, Tandogdu Z, Cai T, Bogenhard F, Wullt B, Naber K, Bartoletti R, Cek M, Kulchavenya E, Perepanova T, Pilatz A, Bonkat G, Erik Bjerklund Johansen T, Wagenlehner F: Transurethral Resection of the Prostate: are We Following the Guidelines? - Outcomes from the Global Prevalence of Infections in Urology (GPIU) Study. J Chemother 31(1):15-22 (2019)
 
Pilatz A, Veeratterapillay R, Köves B, Cai T, Bartoletti R, Wagenlehner F, Bruyère F, Geerlings S, Bonkat G, Pradere B: Update on Strategies to Reduce Infectious Complications After Prostate Biopsy. Eur Urol Focus 5(1):20-28 (2019)
 
Bonkat G, Wagenlehner F: In the Line of Fire: Should Urologists Stop Prescribing Fluoroquinolones as Default? Eur Urol 75(2):205-207 (2019)
 
Bonkat G, Cai T, Veeratterapillay R, Bruyère F, Bartoletti R, Pilatz A, Köves B, Geerlings SE, Pradere B, Pickard R, Wagenlehner FME: Management of Urosepsis in 2018. Eur Urol Focus 5(1):5-9 (2019)
 
Alidjanov JF, Naber KG, Abdufattaev UA, Pilatz A, Wagenlehner FM: Reliability of Symptom-Based Diagnosis of Uncomplicated Cystitis. Urol Int 102(1):83-95 (2019)
 
Bartoletti R, Wagenlehner FME, Bjerklund Johansen TE, Köves B, Cai T, Tandogdu Z, Bonkat G: Management of Urethritis: Is It Still the Time for Empirical Antibiotic Treatments? Eur Urol Focus 5(1):29-35 (2019)